Interplay of Nutrigenomics and Nutrigenetics to Dietary Responses and NCD
Shokhida Rasulova Shukhrat Kizi1*, Boymuradov Shuxrat2, Nikolaus Syrmos3
1*Department of Education and Liberal Arts, INTI International University
2Tashkent State Medical University, Tashkent DSc, Professor of the maxillofacial surgery and dentistry, Tashkent State Medical University, Tashkent, Uzbekistan, 100109
3Human Performance and Health, Aristotle University of Thessaloniki, Thesaaloniki, Macedonia, Greece
*Corresponding Author E-mail: shohida98@gmail.com, pharmacist.rezwan@gmail.com, rabindra.prasad@newinti.edu.my
ABSTRACT:
Background: The replication and stability of cells depend on the human genome, which is encased in chromosomes. Mutations caused by mistakes in DNA replication may increase the risk of non-communicable diseases (NCDs) such cancer, heart disease, and obesity, as well as cause developmental abnormalities. These influences can come from inside and outside the body. Dietary components' interactions with genetic composition and their effects on health outcomes are the focus of nutritional genomics, which includes nutrigenomics and nutrigenetics. Objective: The purpose of this review is to delve into the gene-diet connection by highlighting the contributions of nutrigenomics and nutrigenetics to our knowledge of how different people's diets affect their health and the chances of developing noncommunicable diseases. Method: Publications published between January 2010 and October 2024 were the primary subject of a thorough literature analysis that used databases such as PubMed and Karger. "Nutrition," "nutritional genomics," "nutrigenetics," and "non-communicable diseases" were among the most popular search words. Result: This review compiles research showing that dietary requirements and nutrient metabolism are greatly affected by genetic differences, particularly SNPs. The article emphasizes the need of addressing both undernutrition and overnutrition. Individualized nutritional plans have shown potential in the fight against noncommunicable diseases, especially in at-risk groups like the elderly. Conclusion: In order to enhance health outcomes and minimize illness risks, individualized nutrition programs must take into account the complex relationship between genetics and diet. The increasing number of noncommunicable diseases (NCDs) calls on health officials to put an emphasis on personalized dietary treatments, using new findings in genomics to influence public health policy and dietary recommendations in the future. To better understand the connections between genes and food and to increase the usefulness of nutrigenomics and nutrigenetics in healthcare, further study is required.
KEYWORDS: NCD, Nutrigenetics, Nutrigenomics, Genomic, Nutrition, etc.
INTRODUCTION:
The human genome, which is diploid and ready for replication, is encased in a single cell embryo at the beginning of life. The biggest molecules in a cell, called chromosomes, contain the same genetic material in almost all cells of multicellular organisms1.
There are hundreds of genes on these chromosomes, as well as extensive sections of intergenic DNA2. In order to replace cells that die or are lost, the genome must be precisely copied millions of times throughout development, both during fetal and adult phases, and continuously thereafter3. Mistakes in DNA proofreading may lead to defective replication, which depends on a number of substrates and cofactors. Accumulating such mistakes may cause base sequence or chromosomal level alterations and programmed cell death (apoptosis)4. The role of these mutations, which can be caused by both internal and external genotoxic factors, in developmental abnormalities, premature aging, and increased vulnerability to degenerative diseases such as cancer, infertility, immune dysfunction, cardiovascular disease, and neurodegenerative disorders is being more acknowledged5.
Nutritional genomics, which emerged with the sequencing of the human genome, has replaced the older idea of nutrient-gene interactions6. There are two primary branches of this science: nutrigenomics, which studies the effects of food on genes and protein metabolism and function, and nutrigenetics, which studies how different people's genes react to different foods. Studies have shown that nutrients play a crucial role as cofactors in DNA metabolism and repair, and that dietary variables have a substantial influence on these processes7. The impact of nutritional deficits or excesses on the accuracy of DNA replication is, however, poorly known. Another possible molecular way to investigate nutrition's function in health is via single nucleotide polymorphisms (SNPs), which are common genetic variants that might affect metabolic reactions to food8. A balanced diet is essential for reducing health risks, even if life expectancy has been steadily rising, which is a result of advances in longevity9. The prevention of non-communicable diseases (NCDs) is a top priority for health authorities, who are tackling the dual problems of undernutrition and overnutrition by promoting dietary control that ensures people get the nutrients they need10.
Figure 1: Trends in Growth and Forecasts of Size and Share Analysis of the Nutrigenomics Market for the Years 2024–2033.11
The purpose of this study is to take a close look at the complex web of relationships between genes and nutrition, with a focus on how nutrigenomics and nutrigenetics help us understand how different people's diets affect their health and how to avoid certain diseases. We want to shed light on the impact of genetic differences on food metabolism and dietary requirements by combining current research from many scientific sources. This will be especially helpful in understanding non-communicable diseases (NCDs) including cancer, heart disease, obesity, and diabetes. Personalized nutrition methods may optimize health outcomes and mitigate illness risks. This research aims to emphasize their relevance in shaping future dietary recommendations and health policy. Thorough literature research was carried out using several academic databases, such as PubMed, Karger, Cambridge Press, and IntechOpen, to investigate the function of nutrition in health and wellbeing. So that we could include the most recent findings, we limited our search to articles published between 2010 and 2024. "Nutrition," "nutritional genomics," "nutrigenetics," "non-communicable diseases," "dietary interventions," and "health outcomes" were crucial search keywords used.
Overview of Nutrigenetics and Nutrigenomics:
Dr. R.O. Brennan defined the word "nutrigenetics" in 1975 to describe the study of how a person's genes affect their body's reaction to food12. Some monogenic and polygenic disorders may have their roots in dietary mismatches, according to this area of study that investigates gene-nutrient relationships. Enzyme activity and, by extension, the metabolism of several nutrients and substances, may be influenced by genetic polymorphisms, which in turn can affect general health. For example, phenylketonuria (PKU) and hemochromatosis are metabolic illnesses that may be controlled by dietary adjustments that are specific to each person's genetic makeup13. Mutations in some genes influence nutrition metabolism and the likelihood of developing diseases including cancer and heart problems. Personalized dietary approaches to disease prevention have been emphasized by nutrigenetic research, which also emphasizes the function of single nucleotide polymorphisms (SNPs) in modifying nutrient absorption and metabolism. The intricate relationship between diet and genetics is further shown by several polymorphisms, for example in the glutathione peroxidase, PPAR, and VDR genes, which impact illnesses ranging from cancer to cardiovascular disorders14.
The field of nutrigenomics aims to decipher the genetic and epigenetic mechanisms by which macronutrients and micronutrients affect human health. It uses functional genomic methods to investigate the metabolic pathways and homeostatic regulation affected by nutrition, as well as the effects of nutrients on gene transcription, expression, and the responses of gene variations15. While nutrigenetics aids in customizing customized nutrition by determining the ideal diet for an individual, nutrigenomics seeks to establish optimum diets based on changes in nutrition. This study relies heavily on techniques like metabolomics, transcriptomics, and proteomics. Nutritional factors may influence gene expression by modulating chromatin shape, protein function, and gene activity, according to studies16. Diet has a role in the development of many chronic illnesses, including diabetes, obesity, and cardiovascular disease, which are impacted by a combination of hereditary and environmental variables17. Lipid metabolism and cancer growth are two examples of the many processes that nutrients may influence via their direct and indirect regulation of transcription factors and signal transduction pathways. As an example, a family of nutrient sensors called PPARs affects genes that are involved in the metabolism of the liver. Deficits in micronutrients, such as vitamins B, E, and D, are associated with a number of disorders, whereas dietary compounds, including polyphenols and polyunsaturated fatty acids (PUFAs), influence gene expression. Nutritional cues, such as carbs and amino acids, may also change metabolic pathways and gene expression. Determinants of illness severity, course, and onset are genes that are modulated by chemicals in the food18,19.
Table 1: Illustrating the function and impact of several micronutrient deficits on genome stability20-28.
|
Micronutrients |
Operation in genomic stability |
Result of deficiency |
|
Vits C |
Prevent lipid, DNA oxidation |
Baseline levels of DNA damage, chromosomal breakage, oxidative DNA lesions, and lipid peroxide adducts on DNA are elevated. |
|
Folate and Vits B2, B6, B12 |
Effective recycling of folate, maintenance DNA methylation, and dTMP production from dUMP |
DNA hypomethylation, chromosomal breakage, and uracil misincorporation |
|
Vit D |
Increase antioxidant activity in normalm cells Induce apoptosis in malignant cells |
|
|
Vit E |
Prevent lipid, DNA oxidation |
|
|
Niacin, Nicotinic acid |
Important for DNA cleavage and recombination, telomere length maintenance, and DNA repair; substrate for poly (ADP-ribose) polymerase. |
DNA hypomethylation, chromosomal breakage, and uracil misincorporation |
|
Zn, Mn and Se |
Zinc is an essential element for many biochemical reactions, including those involving DNA replication, P53 activity, endonuclease IV, Cu/Zn supperoxid dismutase, and zinc finger proteins like poly (ADP-ribose) polymerase. The mitochondrial Mn superoxide dismutase enzyme requires manganese, which is a mineral. Selenium, an essential component of glutathione peroxidase and other peroxidases. |
Enhanced chromosomal damage rate, DNA oxidation and breakage |
|
Iron |
Essential for the proper functioning of mitochondrial cytochromes and ribonucleotide reductase. |
Decreased ability to repair DNA, heightened susceptibility to oxidative stress on mitochondrial DNA |
|
Mg2+, Ca2+ |
Several DNA polymerases rely on magnesium as a cofactor; these enzymes are essential for chromosomal segregation and microtubule polymerisation, among other processes. Ca is essential for cell death and has a significant impact on chromosomal segregation. |
Problems with DNA repair, chromosomal segregation, DNA replication fidelity, and the ability of genomically abnormal cells to survive |
Research in the fields of nutrigenomics and nutrigenetics aims to better understand the interplay between genes and nutrition by examining the effects of various nutrients on gene expression and the ways in which genetic variants impact dietary responses29,30. Personalized nutrition strategies for health optimization and illness prevention are the ultimate goal of these areas, which use genetic data and modern 'omic' technology to better understand nutrient-gene interactions31. The effect of cultural and geographical variations on food, the impact of genetic variability across people and ethnic groups that affects nutrient metabolism, and the impact of malnutrition on gene expression and genome stability are all variables that highlight their relevance32,33. Recommended dietary allowances (RDAs), are based on population-level data that may not take into consideration individual variations in nutrient metabolism, highlighting the need of tailored nutrition plans34. Some of the most important ideas in the fields of nutrigenomics and nutrigenetics propose that dietary factors influence gene expression and that changes in genetic makeup influence the processing of nutrients. Genetic vulnerability and gene expression are both significantly impacted by epigenetics, the study of dietary effects on gene regulation35. Personalized nutrition is an exciting new area of study that has the potential to improve health outcomes by shedding details about disease etiology and guiding dietary therapies in accordance with specific genetic profiles36,37.
Impact of Nutrition on Non-Communicable Diseases:
In the last five decades, life expectancy has increased by 5.5 years on average throughout the world, and in many nations, it is already more than 80 years38. Unfortunately, the burden of age-related noncommunicable diseases (NCDs) such as diabetes, cardiovascular disease, and cancer has grown along with the increase in lifespan, putting a strain on both people and healthcare systems39. Organizations like the World Health Organization place a premium on avoiding noncommunicable diseases (NCDs) because of the substantial correlation between NCDs and modifiable risk factors, such as sedentary lifestyles and poor nutrition40. Essential for development and upkeep throughout life, proper nutrition is a key component in health promotion. Thanks to our contemporary lives, we tend to eat a lot of calorie-dense, nutrient-poor foods, which adds to the problem of undernutrition and overnutrition. The yearly economic cost of poor diets and inactivity in the European Union is estimated at €1.3 billion41. Health officials have emphasized cutting down on sugar, salt, fat, and calories, but encouraging people to eat enough of each component is still crucial for maintaining a healthy diet. The need for country-specific guidelines is underscored by differences in nutrient intake and eating habits across time42.
Table 2: Medical Nutrition: Improving Health Status and Clinical Outcomes43.
|
Clinical Nutrition |
Clinical Condition |
Clinical Advantages |
|
Malnutrition Management by Nutrition |
Short Bowel Syndrome; Stroke |
Life-saving moment |
|
COPD |
Enhanced Respiratory Function |
|
|
Older Patients |
Better health, less illness, and longer life expectancy |
|
|
Surgical Patients |
Low Complications |
|
|
Nutritional Disease Management |
Crohn’s Disease |
Remission Induction |
|
Cow’s Milk Allergy |
Lessened Signs, Accelerated Recovery |
|
|
IEMs: PKU, MSUD, FAOD, GSD |
Normal Growth and Development |
|
|
Intractable Epilepsy |
Regular Growth and Development; lower Seizures |
The worldwide epidemic of poor dietary and lack of physical exercise can only be reversed by health policies and programs that target the general public's food consumption. Still, high-risk populations, such the elderly, may need individualized strategies to close chronic dietary deficits and forestall health problems44. In particular, undernourishment affects 5–10% of persons living in the community who are 70 and older, and 30–65% of those confined to nursing homes. Calcium, vitamin D, and vitamin B6 and B12 deficiencies are prevalent in the elderly population45. Reduced sun exposure and inadequate dietary sources of vitamin D have made it a common health problem affecting people of all ages. When this nutrient is missing, it may lead to a host of musculoskeletal problems, such as weak muscles and bones. Vitamin D and calcium taken together greatly lower the risk of fracture, according to studies. This is especially true for those living in institutions. Vitamin K is vital for bone health and has a synergistic impact with vitamin D, according to study46. Vitamin D's effects on health are still up for debate, but current research suggests that tailored supplementation may be helpful, especially for those who are deficient in the vitamin or who are at risk.
Cardiovascular Disease:
The primary cause of morbidity and death, and the main driver of healthcare expenses, is cardiovascular diseases, even though the worldwide mortality rate from these causes has been declining. Conditions including obesity, hypertension, and dyslipidemia are consequences of a sedentary lifestyle, poor nutrition, and cigarette smoking, all of which contribute to cardiovascular ageing. The prevalence of cardiovascular disease is highest among the elderly, affecting 85% of those over the age of 80 and 68% of those between the ages of 60 and 79. There has been a lack of focus on the function of undernutrition in relation to cardiovascular disease, despite the fact that proper nutrition may slow its development47. It is well-known that overnutrition may negatively affect cardiovascular health, but less research has looked at how improving dietary shortages might do the same, particularly in older persons. There has been conflicting evidence on the possible advantages of vitamin D and vitamin B nutrients. Taking vitamin D supplements had no impact on cardiovascular outcomes, while taking B vitamins lowered homocysteine levels but only reduced the risk of stroke considerably48,49. The effectiveness of vitamin supplementation, especially in reducing cardiovascular risks associated with homocysteine, may be further affected by factors including genetic variations. At the same time, research on the cardiovascular preventive benefits of vitamins E and K has shown conflicting findings, especially in some subgroups50–53.
Eye Disorders:
Visual and auditory impairments rank as the second most common forms of disability. Glaucoma, cataracts, diabetic retinopathy, age-related macular degeneration (AMD), and cataracts are among the most prevalent causes of visual loss in the aged population54. Although age is the main factor that increases the likelihood of AMD, other lifestyle and environmental variables, including smoking, oxidative stress, food, and excessive blue light exposure, may also play a role. Carotenoids, especially lutein and zeaxanthin, shield the eyes from potentially damaging blue light and boost retinal antioxidant defences55. Individuals with poor macular pigment optical density may benefit from supplements that enhance visual function and decrease the development of AMD. People with low dietary intake of lutein and zeaxanthin had a decreased chance of developing advanced age-related macular degeneration (AMD) in the AREDS2 study, and this supplement may also decrease the risk of undergoing cataract surgery. If the AREDS2 complex were to be extensively used, it might significantly save healthcare expenses by preventing age-related macular degeneration and cataracts in the elderly. To better prevent age-related eye problems, future studies should investigate the best ways to take these carotenoids and how they interact with other nutrients56.
Nutrigenomic Biomarkers and the Gene-Diet Relationship in Disease:
Protecting against non-communicable diseases (NCDs) such as malignancies, cardiovascular disease, obesity, diabetes, respiratory illness, metabolic syndrome, and obesity-related disorders is the goal of nutrigenomics research, which examines the relationship between genes, nutrition, and disease57. Chronic exposure to certain dietary components, especially those associated with city living and junk food intake, is commonly related with these NCDs. Biomarkers that may lead to the diagnosis of nutritional issues include aberrant lipid profiles, high blood pressure, and insulin sensitivity. These symptoms might be indicators of metabolic syndrome or cardiovascular disease. Proteomics and metabolic changes produced by a person's genotype may be detected with the use of biomarkers, which include proteins, metabolites, and different bodily processes. The presence of DNA adducts, abasic sites, strand breaks, telomere shortening, and mitochondrial DNA damage are some of the ways that molecular DNA damage may be detected58. Research establishing a connection between diet and illness has provided credence to the use of these damaged DNA markers. Among nutritional genomics biomarkers, the micronucleus test in cytokinesis-blocked lymphocytes is the gold standard at the moment. Analyzing gene expression by microarray assays enables the evaluation of hundreds of genes concurrently; transcriptomics is another established method in nutrigenomics. Researchers have discovered disease-specific gene-expression patterns in peripheral blood cells; these patterns have been used as biomarkers for the identification of diseases such as leukemia and breast cancer.
Popular genetic markers that contribute to genetic diversity include single nucleotide variants (SNVs) and single nucleotide polymorphisms (SNPs). By analyzing these changes, genotypic variances may be identified, which in turn allows for personalized dietary advice to avoid NCDs such cancer, heart disease, obesity, and diabetes. Examples include the work of Ramos-Lopez et al., who brought attention to the link between taste perception in Mexico and the sweet taste receptor (TAS1R2), and the link between the CD36 gene and dyslipidemia in those who consume a lot of carbs and fats. The risk of breast cancer is higher in those who do not get enough folate, vitamin B6, or vitamin B12 because of single nucleotide polymorphisms (SNPs) in genes that control homocysteine metabolism, such as MTHFR and MTR59. Osteoporosis and other vitamin D-related disorders may develop in postmenopausal women who don't get enough calcium from their diets because of polymorphisms in the vitamin D receptor (VDR) gene60.
Figure 2: Nutrigenomics and nutrigenetics relationship. Visual representation of individualized strategies to lower cardiovascular disease risk by addressing food patterns and nutritional sensitivity.61,62
Insulin resistance, hypertension, and type-2 diabetes are among the metabolic disorders associated with obesity, a chronic inflammatory sickness. When it comes to the complex interplay between heredity and lifestyle variables like food, sleep, and exercise, nutrigenomics is crucial for making sense of the obesity crisis. Along with being susceptible to environmental variables, genetic susceptibility is a major contributor to obesity, according to research63. Research conducted by Nakamura et al., Nettleton et al., and Reddon et al. supports the idea that hereditary variables impact an individual's susceptibility to obesity, meaning that not everyone exposed to an obesogenic environment will acquire obesity. Consequently, metabolic problems associated with obesity may be better managed with a mix of good eating and frequent exercise.
In their explanation of energy balance, Hill et al. state that when caloric intake is more than caloric expenditure, adipose tissue accumulates triacylglycerol, which promotes obesity. When the energy balance is negative, on the other hand, lipolysis and fatty acid mobilization are encouraged64. Additionally, epigenetic variables are important in obesity; for example, Goldberg et al. discovered that a person's dietary environment during pregnancy and the first few months after giving birth might affect their risk of being overweight later in life. Epigenetic changes, like DNA methylation, control gene expression without changing the DNA sequence, drawing attention to the fact that heredity and environment interact in the context of obesity. In the context of cardiovascular disease (CVD), nutrigenomics has shown that dietary influences on susceptibility to CVD may be influenced by certain genetic polymorphisms. Apolipoprotein E is one example of a lipid transport protein whose polymorphisms influence both cholesterol levels and the likelihood of atherosclerosis, a key risk factor for cardiovascular disease. Consumption of high-fat meals is associated with elevated levels of low-density lipoprotein (LDL) cholesterol in those who have the APOE4 gene. The significance of individualized nutrition in controlling cardiovascular health is underscored by dietary treatments that focus on the macronutrient composition and sources of fat, such as olive oil instead of animal fats, which may substantially affect CVD risk65. Last but not least, nutrigenomics has shown how dietary variables interact with genetic ones to affect cancer risk. Flavonoids, phenols, and omega-3 fatty acids are a few examples of the bioactive substances contained in diet that have been shown to modify carcinogen metabolism and lower cancer risk66. One example is the correlation between a high red meat intake and an increased risk of colorectal cancer, especially in those who have fast-acetylating NAT2 polymorphisms. In addition, vitamins, antioxidants, and dietary fibre may influence gene expression and cellular processes associated with carcinogenesis, which in turn can protect against cancer67.
Maximizing Health and Performance with Nutrigenetics and Nutrigenomics:
There are obvious gender and age-related variances in dietary requirements, but nutrition studies have often assumed that everyone has the same nutritional requirements. Deficiency illnesses are the primary focus of dietary recommendations, which often take the form of Recommended Dietary Allowances (RDAs) and outline the minimum amounts of nutrients that the majority of people should consume each day to be healthy. Although these recommendations are revised on a regular basis to reflect the most recent scientific findings, there is an increasing need for a more sophisticated comprehension of nutritional needs due to the proliferation of nutrition-related chronic disorders68.
Consumers may enter their age, sex, height, weight, and degree of physical activity to get individualized eating plans with the use of the online 'Mypyramid' tool, which is a noteworthy breakthrough in the field of personalized dietary advice. The need for more advanced approaches to dietary personalization is underscored by the fact that this strategy only partly accounts for individual variances. Nutrigenomics and nutrigenetics have recently made strides in understanding how genes and variations impact dietary requirements. Research on these connections in animals and using systems biology methods has yielded some understanding, but there has been little success in applying this information to humans. Still, there's a growing interest in the idea of genetically-based personalized diet69.
There is mounting evidence that people respond differently to medical treatments aimed at preventing and treating illness, which lends credence to the need for tailored dietary plans. Although personalized pharmacology was sluggish to gain traction, it is now showing promise in tackling problems like adverse drug responses by adapting medication selection and dose to individual genetic profiles. As an example, it is becoming normal practice to do genetic testing for variations in medication metabolism, which may improve the effectiveness of therapy. With the increasing desire for personalized consumer goods, there are similar potential in nutrigenomics and nutrigenetics. This suggests that personalized nutrition might be useful in managing some health disorders70.
The successful use of personalized diet is shown by the case of coeliac disease. A gluten-free diet is essential for controlling inflammatory symptoms and preventing major health consequences with this disorder, which is characterized by an unfavorable response to gluten. There is substantial evidence linking specific genetic variations to an increased risk of developing coeliac disease. Currently, genetic screening for coeliac disease is not often done, but it might help identify those who are at risk and then we can implement dietary therapies specifically for them71.
Personalized diet plans have the potential to improve obesity prevention efforts. Weight reduction and maintenance results may be greatly enhanced with individualized meal plans that are influenced by genetic data, according to research. Diet and exercise plans based on individuals' specific genetic variations led to more weight loss and better maintenance of weight loss than those who followed more generalized plans. Although our own pilot research in Auckland showed that individualized diets may be effective, it also showed that people have a hard time sticking to their programs, especially when it comes to exercise. It is becoming more and more crucial to comprehend the hereditary components impacting disorders such as Alzheimer's and Parkinson's as the population becomes older. Dietary therapies have shown some success in animal studies, but we still need to do more study to see if they work for humans. Personalized nutrition is gaining popularity among customers, but it's still a problem for the food sector to satisfy their demands while also catering to their everyday habits and tastes71.
CONCLUSION:
Health outcomes and the prevention of non-communicable diseases (NCDs) may be better understood by examining the complex relationship between genetics and diet. Nutrigenomics and nutrigenetics provide light on how genetic variants impact reactions to food components; this, in turn, reveals that tailored nutrition plans might improve health and reduce the likelihood of illness. The growing number of noncommunicable diseases (NCDs) throughout the world is a clear indication that health officials must act swiftly to advocate for personalized dietary therapies that take genetic variability into consideration. The development of personalized dietary recommendations that suit the specific metabolic demands of people, especially vulnerable groups like the elderly, is made possible by advances in genetic research, which provide a promising foundation. Improved public and individual health outcomes may be achieved by more research into the gene-diet link, the development of more accurate nutritional assessment biomarkers, and the application of genomic findings to real-world dietary recommendations.
ACKNOWLEDGEMENT:
The authors thank to the INTI University, Malaysia and this review work is supported by INTI University.
REFERENCES:
1. Ames BN. Low micronutrient intake may accelerate the degenerative diseases of aging through allocation of scarce micronutrients by triage. Proc Natl Acad Sci USA. 2006; 103: 17589-175894. http://doi.org/10.1073/pnas.0608757103
2. Fenech M. Genome health nutrigenomics and nutrigenetics-diagnosis and nutritional treatment of genome damage on an individual basis. Food Chem Toxicol. 2008; 46: 1365-1370. http://doi.org/10.1016/j.fct.2007.06.035
3. Fenech M. Recommended dietary allowances (RDAs) for genomic stability. Mutat Res. 2001; 480-481: 51-54. http://doi.org/10.1016/s0027-5107(01)00168-3
4. De Flora S, Izzotti A. Mutagenesis and cardiovascular diseases: molecular mechanisms, risk factors, and protective factors. Mutat Res. 2007; 621: 5-17. http://doi.org/10.1016/j.mrfmmm.2006.12.008
5. Coppedè F, Migliore L. DNA damage and repair in Alzheimer’s disease. Curr Alzheimer Res. 2009; 6: 36-47. http://doi.org/10.2174/156720509787313970
6. Subbiah MT. Nutrigenetics and nutraceuticals: the next wave riding on personalized medicine. Transl Res. 2007; 149(2): 55–61. http://doi.org/10.1016/j.trsl.2006.09.003.
7. Farhud D, Zarif Yeganeh M, Zarif Yeganeh M. Nutrigenomics and nutrigenetics. Iran J Public Health. 2010; 39(4): 1-14.
8. Bruins MJ, Van Dael P, Eggersdorfer M. The Role of Nutrients in Reducing the Risk for Noncommunicable Diseases during Aging. Nutrients. 2019; Jan 4; 11(1): 85. http://doi.org/10.3390/nu11010085.
9. Fenech M, El-Sohemy A, Cahill L, Ferguson LR, French TAC, Tai ES, et al. Nutrigenetics and nutrigenomics: Viewpoints on the current status and applications in nutrition research and practice. Lifestyle Genom. 2011; 4(2): 69–89. Available from: http://doi.org/10.1159/000327772
10. Mondal S, Panda D. Nutrigenomics: An interface of gene-diet-disease interaction. In: Mózsik G, Díaz-Soto G, editors. Mineral Deficiencies - Electrolyte Disturbances, Genes, Diet and Disease Interface. London, England: IntechOpen; 2021. http://doi.org/10.5772/intechopen.94602
11. CoherentMI. Nutrigenomics Market - companies, size, share and research analysis. 2024
12. Simopoulos AP. Genetic variants in the metabolism of omega-6 and omega-3 fatty acids: their role in the determination of nutritional requirements and chronic disease risk. Experi Biol Med. 2010; 235: 785–95. http://doi.org/10.1258/ebm.2010.009298.
13. Ordovas JM. Nutrigenetics, Plasma Lipids, and Cardiovascular Risk. J Am Diet Assoc. 2006; 106(7): 1074–81. http://doi.org/10.1016/j.jada.2006.04.016.
14. Stover Patrick J. Nutritional genomics. Physiol Genomics. 2004; 16(2): 161–5. http://doi.org/10.1152/physiolgenomics.00204.2003.
15. El-Sohemy A. The Science of Nutrigenomics. Health Law Review. 2008; 16(3): 5–8.
16. Iacoviello L, Santimone I, Latella MC, de Gaetano G, Donati MB. Nutrigenomics: a case for the common soil between cardiovascular disease and cancer. Genes Nutr. 2008; 3(1): 19–24 http://doi.org/10.1007/s12263-008-0079-0.
17. Fenech M. Nutrition and genome health. Forum Nutr. 2007; 60: 49–65. http://doi.org/10.1159/000107067.
18. Stryjecki C, Mutch DM. Fatty acid-gene interactions, adipokines and obesity. Eur J Clin Nutr. 2011; 65: 285-97. http://doi.org/10.1038/ejcn.2010.277
19. Desmarchelier C, Borel P, Goncalves A, Kopec R, Nowicki M, Morange S, Lesavre N, Portugal H, Reboul E. A combination of single-nucleotide polymorphisms is associated with interindividual variability in cholecalciferol bioavailability in healthy men. J Nutr. 2016; 146: 2421-2428. http://doi.org/10.3945/jn.116.237115
20. Mankurani Goel, Yogita Gupta. A Study on: Poor Dietary Habits. Asian Journal of Management. 2023; 14(2): 118-0. http://doi.org/10.1017/10.5958/2349-2996.2016.00026.4
21. Jesna M Joy, Reenu Jose Antony, Shanmuga Sundaram Rajagopal. Dietary Fiber Intake and Benefit of Colorectal Cancer. Asian J. Res. Pharm. Sci. 2019; 9(3): 209-214. http://doi.org/10.1017/10.5958/2231-5659.2019.00033.X
22. Shwetha M. N, Nancy Chandra Priya. P. Knowledge regarding vitamin D deficiency among students. Asian J. Nursing Education and Research. 2019; 9(1): 66-68. http://doi.org/10.1017/10.5958/2349-2996.2019.00013.2
23. Rohit Avasthi, Bhartendra Sharma, Giriraj Prasad Soni. Prevalence and Clinical Spectrum of Vitamin B-12 Deficiency in A Cohort of patient Presenting with Neurological Disorders in Tertiary Care Hospital of Rajasthan. Asian Journal of Nursing Education and Research. 2023; 13(2): 88-2. http://doi.org/10.1017/10.52711/2349-2996.2023.00019
24. Rahul Jodh, Mukund Tawar, Gaurav Mude, Apurva Fasate, Renuka Sutane, Purvaja Patanray. An Updated Review on Vitamin C-An Excellent Drug Having a Great Scavenging Property. Asian Journal of Pharmaceutical Research. 2023; 13(1): 25-0. http://doi.org/10.1017/10.52711/2231-5691.2023.00004
25. Nitin Mahurkar, S.M. Sayeed Ul Hasan, Arati A. Malpani. Gastroprotective Influence of Vitamin C and its Combination with Rabeprazole in Pylorus Ligation Induced Ulcers. Asian J. Res. Pharm. Sci. 2014; 4(2): 71-76.
26. Vijay K Patel, Chirag Kpatel, Harsha U Patel, CN Patel. Vitamins, Minerals and Carotenoids as a Antioxidants. Asian J. Research Chem. 2010; 3(2): 255-260.
27. 27.Tapan Seal. Nutritive scenario of wild consumable plants of Meghalaya state in India together with heavy metals, anti-nutritional, vitamin and toxicity studies. Res. J. Pharmacognosy and Phytochem. 2020; 12(3): 123-134. http://doi.org/10.1017/10.5958/0975-4385.2020.00031.X
28. Rupali Kirtawade, Pallavi Salve, Anita Kulkarni, Pandurang Dhabale. Herbal antioxidant: Vitamin C. Research J. Pharm. and Tech. 2010; 3(1): 58-61.
29. Hill JO, Wyatt HR, Peters JC. Energy balance and obesity. Circulation. 2012; 126: 126-132. http://doi.org/10.1161/CIRCULATIONAHA.111.087213
30. Juma S, Imrhan V, Vijayagopal P, Prasad C, (2014). Prescribing Personalized Nutrition for Cardiovascular Health: Are We Ready? J Nutrigenet Nutrigenomics. 2014; 7: 153-160. http://doi.org/10.1159/000370213
31. Georgoulis M, Kontogianni MD, Yiannakouris N. Mediterranean diet and diabetes: Prevention and treatment. Nutrients. 2014;6:1406-1423. http://doi.org/10.3390/nu6041406
32. Xiao JB, Högger P. Dietary polyphenols and Type 2 diabetes: Current insights and future perspectives. Curr Med Chem. 2015; 22: 23-38. http://doi.org/10.2174/0929867321666140706130807
33. Lin D, Xiao M, Zhao J, Li Z, Xing B, Li X, Kong M, Li L, Zhang Q , Liu Y, et al. An overview of plant phenolic compounds and their importance in human nutrition and management of type 2 diabetes. Molecules. 2016; 21: 1374. http://doi.org/10.3390/molecules21101374
34. Hanhineva K, Törrönen R, Bondia-Pons I, Pekkinen J, Kolehmainen M, Mykkänen H, Poutanen K. Impact of dietary polyphenols on carbohydrate metabolism. Int J Mol Sci. 2010;11:1365-1402. http://doi.org/10.3390/ijms11041365
35. Kerimi A, Williamson G. At the interface of antioxidant signalling and cellular function: Key polyphenol effects. Mol Nutr Food Res. 2016; 60: 1770-1788. http://doi.org/10.1002/mnfr.201500940
36. Babu PVA, Liu D, Gilbert ER. Recent advances in understanding the anti-diabetic actions of dietary flavonoids. J Nutr Biochem. 2013; 24: 1777-1789. http://doi.org/10.1016/j.jnutbio.2013.06.003
37. Gregori D, Foltran F, Verduci E, Ballali S, Franchin L, Ghidina M, et al. A genetic perspective on nutritional profiles: do we still need them? J Nutrigenet Nutrigenomics. 2011; 4: 25-35. http://doi.org/10.1159/000322569
38. Troesch B., Biesalski H.K., Bos R., Buskens E., Calder P.C., Saris W.H., Spieldenner J., Verkade H.J., Weber P., Eggersdorfer M. Increased Intake of Foods with High Nutrient Density Can Help to Break the Intergenerational Cycle of Malnutrition and Obesity. Nutrients. 2015;7:6016–6037. http://doi.org/10.3390/nu7075266
39. Eggersdorfer M., Walter P. Emerging nutrition gaps in a world of affluence—Micronutrient intake and status globally. Int. J. Vitam. Nutr. Res. 2011; 81: 238–239. http://doi.org/10.1024/0300-9831/a000068.
40. Hoeft B., Weber P., Eggersdorfer M. Micronutrients—A global perspective on intake, health benefits and economics. Int. J. Vitam. Nutr. Res. 2012; 82: 316–320. http://doi.org/10.1024/0300-9831/a000125.
41. Mertens E., Kuijsten A., Dofkova M., Mistura L., D’Addezio L., Turrini A., Dubuisson C., Favret S., Havard S., Trolle E., et al. Geographic and socioeconomic diversity of food and nutrient intakes: A comparison of four European countries. Eur. J. Nutr. 2018 http://doi.org/10.1007/s00394-018-1673-6.
42. Drewnowski A. Nutrient density: Addressing the challenge of obesity. Br. J. Nutr. 2018; 120: S8–S14. http://doi.org/10.1017/S0007114517002240.
43. Kalache A, de Hoogh I, Howlett SE, et al. Nutrition interventions for healthy ageing across the lifespan: a conference report. Eur J Nutr. Supplement. 2019 http://doi.org/10.1007/s00394-019-02027-z
44. Ford J.A., MacLennan G.S., Avenell A., Bolland M., Grey A., Witham M., Group R.T. Cardiovascular disease and vitamin D supplementation: Trial analysis, systematic review, and meta-analysis. Am. J. Clin. Nutr. 2014; 100: 746–755. http://doi.org/10.3945/ajcn.113.082602.
45. Huang T., Chen Y., Yang B., Yang J., Wahlqvist M.L., Li D. Meta-analysis of B vitamin supplementation on plasma homocysteine, cardiovascular and all-cause mortality. Clin. Nutr. 2012; 31: 448–454. http://doi.org/10.1016/j.clnu.2011.01.003.
46. DiNicolantonio J.J., Bhutani J., O’Keefe J.H. The health benefits of vitamin K. Open Heart. 2015; 2: e000300. http://doi.org/10.1136/openhrt-2015-000300.
47. Chen Y., Michalak M., Agellon L.B. Importance of Nutrients and Nutrient Metabolism on Human Health. Yale J. Biol. Med. 2018;91:95–103.
48. Raederstorff D., Wyss A., Calder P.C., Weber P., Eggersdorfer M. Vitamin E function and requirements in relation to PUFA. Br. J. Nutr. 2015; 114: 1113–1122. http://doi.org/10.1017/S000711451500272X
49. Juraschek S.P., Guallar E., Appel L.J., Miller E.R., III Effects of vitamin C supplementation on blood pressure: A meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 2012; 95: 1079–1088. http://doi.org/10.3945/ajcn.111.027995.
50. Forman J.P., Scott J.B., Ng K., Drake B.F., Suarez E.G., Hayden D.L., Bennett G.G., Chandler P.D., Hollis B.W., Emmons K.M., et al. Effect of vitamin D supplementation on blood pressure in blacks. Hypertension. 2013; 61: 779–785. http://doi.org/10.1161/HYPERTENSIONAHA.111.00659.
51. Asleh R., Briasoulis A., Berinstein E.M., Wiener J.B., Palla M., Kushwaha S.S., Levy A.P. Meta-analysis of the association of the haptoglobin genotype with cardiovascular outcomes and the pharmacogenomic interactions with vitamin E supplementation. Pharmacogenom. Pers. Med. 2018; 11: 71–82. http://doi.org/10.2147/PGPM.S159454.
52. Sadia Afrin, Md. Shanzid Hasan, Md. Rezwan Ahmed Mahedi, Ovijet Chandra Kuri, Hrishik Iqbal, Mustafa Jawad Kadham, Mohammad Jamali, Patrik Viktor, Calvin R. Wei, Fredmoore Orosco, Akter Hossain Khan, Nikolaos Syrmos, Fazle Rabbi. Eltrombopag Olamine in Dengue Fever: Systematic Review of Clinical Trials and Beyond. Research Journal of Pharmacy and Technology. 2024; 17(6): 2778-2. http://doi.org/10.1017/10.52711/0974-360X.2024.00436
53. Bernstein P.S., Li B., Vachali P.P., Gorusupudi A., Shyam R., Henriksen B.S., Nolan J.M. Lutein, zeaxanthin, and meso-zeaxanthin: The basic and clinical science underlying carotenoid-based nutritional interventions against ocular disease. Prog. Retin. Eye Res. 2016; 50: 34–66. http://doi.org/10.1016/j.preteyeres.2015.10.003.
54. Hammond B.R., Fletcher L.M., Roos F., Wittwer J., Schalch W. A double-blind, placebo-controlled study on the effects of lutein and zeaxanthin on photostress recovery, glare disability, and chromatic contrast. Investig. Ophthalmol. Vis. Sci. 2014; 55: 8583–8589. http://doi.org/10.1167/iovs.14-15573.
55. Nolan J.M., Power R., Stringham J., Dennison J., Stack J., Kelly D., Moran R., Akuffo K.O., Corcoran L., Beatty S. Author Response: Comments on Enrichment of Macular Pigment Enhances Contrast Sensitivity in Subjects Free of Retinal Disease: CREST—Report 1. Investig. Ophthalmol. Vis. Sci. 2016; 57: 5416. http://doi.org/10.1167/iovs.16-20498.
56. Fenech MF. Dietary reference values of individual micronutrients and nutriomes for genome damage prevention: current status and a road map to the future. Am J Clin Nutr. 2010; 9(1): 1438S–1454S. http://doi.org/10.3945/ajcn.2010.28674D
57. Hosseini-Esfahani F, Mirmiran P, Daneshpour MS, Mehrabi Y, Hedayati M, Zarkesh M, Azizi F. Western dietary pattern interaction with APOC3 polymorphism in the risk of metabolic syndrome. Tehran Lipid and Glucose Study. J Nutrigenet Nutrigenomics. 2014; 7: 105-117. http://doi.org/10.1159/000365445
58. Goni L, Cuervo M, Milagro FI, Martínez JA. A genetic risk tool for obesity predisposition assessment and personalized nutrition implementation based on macronutrient intake. Genes Nutr. 2015; 10: 445. http://doi.org/10.1007/s12263-014-0445-z
59. Nettleton JA, Follis JL, Ngwa JS, Smith CE, Ahmad S, Tanaka T, et al. Gene x dietary pattern interactions in obesity: Analysis of up to 68,317 adults of European ancestry. Hum Mol Genet. 2015; 24: 4728-4738. http://doi.org/10.1093/hmg/ddv186
60. International Diabetes Federation. IDF Diabetes Atlas, 6th ed.; International Diabetes Federation: Brussels, Belgium; 2013. 11p
61. Kerimi A, Williamson G. At the interface of antioxidant signalling and cellular function: Key polyphenol effects. Mol Nutr Food Res. 2016; 60: 1770-1788. http://doi.org/10.1002/mnfr.201500940
62. Debusk RM, Fogarty CP, Ordovas JM, Kornman KS. Nutritional genomics in practice: where do we begin? J Am Diet Assoc. 2010; 105: 589-598. http://doi.org/10.1016/j.jada.2005.01.002
63. Qasim Ali M, Deb A, Hasan MDS, Rahman M, Rahman H, Afrin S, et al. Cadmium toxicity in nature generates the cancerous problems. Pollut Res. 2022; 41(04): 1151–6. http://doi.org/10.53550/pr.2022.v41i04.002
64. Rahman Bhuiyan MK, Rahman DM, Kumar Das S, Shahidul Islam DSM, Mahmud DF, Mukit A, et al. Current aspects of non Hodgkin lymphoma (NHL) in Bangladesh: A mini review. clin med and helt res jour. 2023; 3(01): 312–6. http://doi.org/10.18535/cmhrj.v3i01.130
65. Barrea L, Annunziata G, Bordoni L, Muscogiuri G, Colao A, Savastano S, et al. Nutrigenetics—personalized nutrition in obesity and cardiovascular diseases. Int J Obes Suppl. 2020; 10(1): 1–13. Available from: http://doi.org/10.1038/s41367-020-0014-4
66. Dallio M, Romeo M, Gravina AG, Masarone M, Larussa T, Abenavoli L, et al. Nutrigenomics and nutrigenetics in metabolic- (dysfunction) associated fatty liver disease: Novel insights and future perspectives. Nutrients. 2021; 13(5): 1679. Available from: http://doi.org/10.3390/nu13051679
67. Bull C, Fenech M. Genome health nutrigenomics and nutrigenetics: nutritional requirements for chromosomal stability and telomere maintenance at the individual level. Proc Nutr Soc. 2008; 67(2): 146–56. http://doi.org/10.1017/S0029665108006988.
68. Stover PJ, Caudill MA. Genetic and Epigenetic Contributions to Human Nutrition and Health: Managing Genome-Diet Interactions. 2008.
69. Hardy TM, Tollefsbol TO. Epigenetic diet: impact on the epigenome and cancer. Epigenomics. 2011; 3(4): 503-518. http://doi.org/10.2217/epi.11.71
70. Komduur RH, Korthals M, te Molder H. The good life: living for health and a life without risks? On a prominent script of nutrigenomics. Br J Nutr. 2011; 101: 307-316. http://doi.org/10.1017/S0007114508076253
71. Afzal S, Iftikhar A, Ahmad M, Ashraf Z, Khalid W, Ali SW, Illyas M, Afzal F, Khalid MZ, Alsulami T, Mukonzo EL. Evaluating eating patterns and health status of undergraduate students majoring in human nutrition, Lahore, Pakistan: a cross-sectional study. Int J Adolesc Youth. 2025;30(1):Article 2448287. https://doi.org/10.1080/02673843.2024.2448287
|
Received on 06.11.2024 Revised on 20.03.2025 Accepted on 26.05.2025 Published on 13.01.2026 Available online from January 17, 2026 Research J. Pharmacy and Technology. 2026;19(1):411-419. DOI: 10.52711/0974-360X.2026.00060 © RJPT All right reserved
|
|
|
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Creative Commons License. |
|